Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 23, 2024
Date Accepted: Jun 24, 2024

The final, peer-reviewed published version of this preprint can be found here:

The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial

Pearson R, Beevers CG, Mignogna J, Benzer J, Pfeiffer PN, Post E, Creech SK

The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2024;13:e59119

DOI: 10.2196/59119

PMID: 39446432

PMCID: 11544330

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Protocol for a Randomized Controlled Trial of Deprexis: Evaluation of a Computerized Intervention to Decrease Depression and Restore Functioning in Veterans

  • Rahel Pearson; 
  • Christopher G. Beevers; 
  • Joseph Mignogna; 
  • Justin Benzer; 
  • Paul N. Pfeiffer; 
  • Edward Post; 
  • Suzannah K. Creech

ABSTRACT

Background:

Background:

Depressive symptoms are common in Veterans, and the presence of these symptoms increases disability and suicidal thoughts and behaviors. There is, however, evidence that these symptoms often go untreated. Intervening before symptoms are severe and entrenched is related to better long-term outcomes, including improved functioning and less disease chronicity. Computer-delivered interventions may be especially appropriate for those Veterans with mild-moderate depressive symptoms, as these interventions can require fewer resources and have lower barriers to access, and thus have potential for wider reach. Despite this potential, there is a dearth of research examining computerized interventions for depressive symptoms in Veteran samples.

Objective:

Objective:

The aim of this study is to evaluate the efficacy of Deprexis, a computerized intervention for depressive symptoms and related functional impairment.

Methods:

Methods:

First, qualitative interviews will be completed with a small subset of Veterans (n=16-20) to assess acceptability of procedures. Then, Veterans (n=132) with mild-moderate depressive symptoms will be randomly assigned to the Deprexis intervention or a treatment-as-usual control group. Primary outcomes will be depressive symptoms and various dimensions of psychosocial functioning.

Results:

Results:

Recruitment is expected to begin in April 2024, with initial results expected in April 2029.

Conclusions:

Conclusion: This study will provide initial evidence for the efficacy of self-guided computerized interventions for depressive symptoms and functional impairment in Veterans. If effective, these types of interventions could improve treatment access to psychosocial interventions for Veterans receiving care in the VA. Clinical Trial: ClinicalTrials.gov ID: NCT06217198


 Citation

Please cite as:

Pearson R, Beevers CG, Mignogna J, Benzer J, Pfeiffer PN, Post E, Creech SK

The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2024;13:e59119

DOI: 10.2196/59119

PMID: 39446432

PMCID: 11544330

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.